- Lupin today announced the launch of Sevelamer Hydrochloride Tablets, 800 mg, having received an approval from the United States Food and Drug Administration (FDA). The product will be manufactured at Lupin’s facility in Nagpur, India.
- Sevelamer Hydrochloride Tablets, 800 mg is a generic equivalent of Renagele Tablets, 800 mg of Genzyme Corporation.
- Sevelamer Hydrochloride Tablets, 800 mg (RLD: Renagel•) had estimated annual sales of USO 75 million in the U.S. (IQVIA MAT December 2021).
Lupin Launches Sevelamer Hydrochloride Tablets in the United States
Related Posts
Leave a Reply
Recent News
